|
On The Fly
| ShowHide Related Items >><< - 11/07/22
- XPeng rises 9.7%
- 11/01/22
- XPeng obtains autonomous driving test for G9
- 11/01/22
- Xpeng delivers 5,101 Smart EVs in October
- 10/24/22
- XPeng falls -14.9%
- 11/10/22
- Wayfair rises 32.9%
- 10/11/22
- Wayfair selects Google Cloud in shift to unified public cloud strategy
- 08/19/22
- Wayfair falls -17.4%
- 08/19/22
- Wayfair falls -10.6%
- 09/21/22
- Stem appoints Michael Carlson as COO
- 09/20/22
- Stem in joint solar, storage, and EV charging offering with InCharge Energy
- 11/10/22
- Royal Caribbean opens $125M cruise terminal in Galveston with Allure of the Seas
- 11/03/22
- Royal Caribbean sees returning to historical load factors in early summer 2023
- 11/03/22
- Royal Caribbean: Trifecta program to increase adjusted EPS to double digits
- 11/03/22
- Royal Caribbean: FY23 booked well within historical ranges
- 10/10/22
- Procept BioRobotics announces $52M debt refinancing
- 09/19/22
- Procept BioRobotics, Providence enter multi-system, national contract
- 06/09/22
- Procept announces positive coverage policies for Aquablation therapy
- 08/29/22
- NexGen Energy rises 8.6%
- 08/29/22
- NexGen Energy rises 8.6%
- 07/15/22
- NexGen Energy announces CNSC acceptance of EIS submission
- 06/21/22
- NexGen Energy announces Rook I Project EIS
NTLA Intellia Therapeutics - 11/06/22
- Intellia presents interim data from cardiomyopathy arm of Phase 1 study of '2001
- 09/19/22
- Cathie Wood's ARK Investment bought 71K shares of Intellia Therapeutics today
- 09/16/22
- Intellia, Regeneron announce initial data from Phase 1 study of NTLA-2001
- 09/16/22
- Intellia Therapeutics, Regeneron report results of Phase 1 study of NTLA-2001
- 10/25/22
- Marqeta announces partnership with Raiffeisen Centrobank
- 10/24/22
- Marqeta announces release of 'Marqeta for Banking' portfolio of products
- 10/06/22
- Uber partners with Marqeta, MasterCard and Branch on Uber Pro Card
- 09/15/22
- Marqeta announces $100M share repurchase program
- 11/03/22
- Kymera Therapeutics appoints Sandor to board of directors
- 11/03/22
- Kymera Therapeutics expects cash to fund plans at least into 2025
- 11/03/22
- Kymera Therapeutics announces anticipated upcoming milestones
- 11/01/22
- Kymera Therapeutics director sells $8.7M in common stock
- 10/21/22
- Farfetch announces first cohort of start-ups for Dream Assembly Base Camp
- 08/29/22
- Farfetch falls -11.9%
- 08/26/22
- Farfetch rises 27.3%
- 08/26/22
- Farfetch rises 24.4%
- 11/10/22
- Enovix names Ajay Marathe COO
- 11/07/22
- Enovix appoints T.J. Rodgers as Executive Chairman
- 11/01/22
- Enovix announces advancements to Laser Technology Program
- 11/01/22
- Enovix signs MOU with consumer electronics company
- 09/21/22
- DigitalBridge CEO buys $487K in common stock
- 09/14/22
- DigitalBridge reinstates dividend with 1c per share
- 08/23/22
- DigitalBridge completes one-for-four reverse stock split
- 07/14/22
- Deutsche Telekom to sell 51% of GD Towers to Digital Bridge and Brookfield
- 05/16/22
- Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe
- 11/03/22
- Carnival says Arnold Donald to step down from board of directors
- 10/27/22
- Carnival expands installation of Air Lubrication Systems to majority of brands
- 10/27/22
- Carnival expands program for installation of Air Lubrication Systems
- 10/18/22
- Carnival rises 8.8%
- 10/27/22 Tigress Financial
- Tigress Financial sees 45% 12-month upside in Carnival shares
- 10/12/22 UBS
- Carnival price target lowered to $8 from $11 at UBS
- 10/12/22 UBS
- UBS upgrades Norwegian Cruise to Buy on improved bookings
- 10/07/22 Deutsche Bank
- Carnival price target lowered to $10 from $14 at Deutsche Bank
- 10/31/22 BTIG
- Procept BioRobotics initiated with a Neutral at BTIG
- 10/25/22 Truist
- Procept BioRobotics initiated with a Buy, $58 price target at Truist
- 10/25/22 Truist
- Procept BioRobotics initiated with a Buy at Truist
- 09/02/22 Wells Fargo
- Procept BioRobotics initiated with an Overweight at Wells Fargo
- 11/07/22 Raymond James
- DigitalBridge price target lowered to $34 from $38 at Raymond James
- 11/07/22 Cowen
- DigitalBridge price target lowered to $27 from $33 at Cowen
- 09/19/22 B. Riley
- DigitalBridge positive developments 'under the radar,' says B. Riley
- 06/16/22 B. Riley
- B. Riley adds WideOpenWest to '25 Picks for 2022' list, removes DigitalBridge
- 11/03/22 DA Davidson
- Confluent price target lowered to $33 from $44 at DA Davidson
- 11/03/22 Credit Suisse
- Confluent price target lowered to $55 from $65 at Credit Suisse
- 11/03/22 Barclays
- Confluent price target lowered to $27 from $30 at Barclays
- 11/01/22 Citi
- Confluent price target lowered to $30 from $32 at Citi
- 10/25/22 Morgan Stanley
- Farfetch price target lowered to $26 from $32 at Morgan Stanley
- 10/12/22 Wells Fargo
- Wells names Farfetch 'Top Pick' after Platform Solutions deep dive
- 10/11/22 Morgan Stanley
- Farfetch recent deals 'underappreciated and mis-priced,' says Morgan Stanley
- 09/26/22 Citi
- Farfetch initiated with a Sell at Citi
- 11/08/22 Raymond James
- Kymera Therapeutics initiated with a Market Perform at Raymond James
- 11/07/22 B. Riley
- Kymera Therapeutics price target lowered to $35 from $50 at B. Riley
- 08/31/22 JPMorgan
- Kymera selloff a 'misplaced knee-jerk reaction,' says JPMorgan
- 08/15/22 Jefferies
- Kymera Therapeutics initiated with a Buy at Jefferies
- 10/21/22 Tigress Financial
- Royal Caribbean shares have upside to $80, says Tigress Financial
- 10/12/22 UBS
- Royal Caribbean price target lowered to $56 from $65 at UBS
- 10/04/22 Morgan Stanley
- Carnival price target lowered to $6 from $7 at Morgan Stanley
NTLA Intellia Therapeutics - 11/03/22 Chardan
- Intellia Therapeutics price target lowered to $121 from $146 at Chardan
- 10/31/22 EF Hutton
- Intellia Therapeutics initiated with a Buy at EF Hutton
- 10/11/22 Morgan Stanley
- Intellia Therapeutics initiated with an Overweight at Morgan Stanley
- 09/21/22 JPMorgan
- JPMorgan starts Intellia with Overweight, adds to Focus List
- 05/25/22 Raymond James
- NexGen Energy removed from Analyst Current Favorites list at Raymond James
- 04/22/22 Canaccord
- NexGen Energy price target raised to C$10.75 from C$10 at Canaccord
- 04/11/22 RBC Capital
- NexGen Energy upgraded to Outperform from Sector Perform at RBC Capital
- 03/03/22 Raymond James
- NexGen Energy price target raised to C$9 from C$8.50 at Raymond James
- 10/25/22 UBS
- Stem initiated with a Buy at UBS on leading position in commercial storage
- 10/25/22 UBS
- Stem initiated with a Buy at UBS
- 09/29/22 Guggenheim
- Stem price target raised to $17 at Guggenheim after analyst day
- 09/29/22 Susquehanna
- Stem guidance shows acceleration in sales, says Susquehanna
- 10/28/22 Citi
- Citi double downgrades XPeng on 'serious challenges' in 2023
- 10/28/22 Citi
- XPeng downgraded to Sell from Buy at Citi
- 10/28/22 Barclays
- XPeng price target lowered to $8 from $22 at Barclays
- 09/22/22 Morgan Stanley
- XPeng pullback triggered by lack of meaningful G9 surprise, says Morgan Stanley
- 11/04/22 Janney Montgomery Scott
- Janney starts Enovix with Buy after earnings sellofff
- 11/04/22 Janney Montgomery Scott
- Enovix initiated with a Buy at Janney Montgomery Scott
- 11/02/22 Cowen
- Enovix price target lowered to $25 from $36 at Cowen
- 10/27/22 EF Hutton
- Enovix initiated with a Buy at EF Hutton
- 11/07/22 RBC Capital
- Wayfair price target lowered to $35 from $62 at RBC Capital
- 11/07/22 Truist
- Wayfair price target lowered to $50 from $60 at Truist
- 11/06/22 Barclays
- Wayfair price target lowered to $34 from $50 at Barclays
- 10/31/22 Truist
- Wayfair price target lowered to $60 from $96 at Truist
- 11/09/22 DA Davidson
- Marqeta initiated with a Neutral at DA Davidson
- 10/20/22 Wedbush
- Marqeta to present at next week's Money2020 event, says Wedbush
- 10/10/22 Keefe Bruyette
- Marqeta price target lowered to $8 from $10 at Keefe Bruyette
- 09/28/22 Wedbush
- Endava price target lowered to $90 from $120 at Wedbush
- 08/23/22
- XPeng sees Q3 revenue RMB6.8B-RMB7.2B, up 18.9%-25.9% from last year
- 08/23/22
- XPeng reports Q2 no-GAAP EPS (43c), consensus ($2.61)
- 08/23/22
- XPeng reports Q2 EPS (47c), consensus ($2.61)
- 05/23/22
- XPeng sees Q2 revenue up 80.8%-99.4% y-o-y to RMB6.8B-RMB7.5B
- 11/03/22
- Wayfair reports Q3 EPS ($2.11), consensus ($2.15)
- 08/04/22
- Wayfair sees Q3 revenue below Q2, consensus $3.11B
- 11/03/22
- Stem reports Q3 EPS (22c), consensus (17c)
- 08/04/22
- Stem backs FY22 revenue view of $350M-$425M, consensus $391.1M
- 08/04/22
- Stem reports Q2 EPS (21c), consensus (18c)
- 11/03/22
- Royal Caribbean sees Q4 adjusted EPS ($1.50)-($1.30), consensus (67c)
- 11/03/22
- Royal Caribbean reports Q3 adjusted EPS 26c, consensus 19c
- 11/02/22
- Notable companies reporting before tomorrow's open
- 11/03/22
- Procept BioRobotics raises FY22 revenue view to $72.5M from $66M-$68M
- 11/03/22
- Procept BioRobotics reports Q3 EPS (51c), consensus (48c)
- 08/04/22
- Procept BioRobotics raises FY22 revenue view to $66M-$68M from $58M-$62M
- 08/04/22
- Procept BioRobotics reports Q2 EPS (43c), consensus (48c)
NTLA Intellia Therapeutics - 11/03/22
- Intellia Therapeutics reports Q3 EPS ($1.49), consensus ($1.28)
- 08/04/22
- Intellia Therapeutics reports Q2 EPS ($1.33), consensus ($1.31)
- 11/09/22
- Marqeta sees Q4 revenue up 29%-31%, consensus $191M
- 11/09/22
- Marqeta reports Q3 EPS (10c), consensus (9c)
- 11/09/22
- Notable companies reporting after market close
- 08/10/22
- Marqeta sees Q3 revenue growth 36%-38%, consensus $180.05M
- 11/03/22
- Kymera Therapeutics reports Q3 EPS (79c), consensus (74c)
- 08/09/22
- Kymera Therapeutics reports Q2 EPS (78c), consensus (72c)
- 08/25/22
- Farfetch reports Q2 EPS (21c), consensus (32c)
- 05/26/22
- Farfetch reports Q1 EPS (24c), consensus (28c)
- 11/01/22
- Enovix sees 2022 revenue $6M-$8M, consensus $6.62M
- 11/01/22
- Enovix reports Q3 EPS (53c), consensus (16c)
- 05/11/22
- Enovix reports Q1 EPS (16c), consensus (16c)
- 11/04/22
- DigitalBridge reports Q3 EPS (39c), consensus (21c)
- 08/04/22
- DigitalBridge reports Q2 EPS (4c), consensus (4c)
- 11/02/22
- Confluent raises FY22 EPS view to (65c)-(63c) from (73c)-(69c), consensus (70c)
- 11/02/22
- Confluent sees Q4 adjusted EPS (16c)-(14c), consensus (17c)
- 11/02/22
- Confluent reports Q3 adjusted EPS (13c), consensus (17c)
- 08/03/22
- Confluent raises FY22 EPS view to (73c)-(69c) from (79c)-(73c), consensus (75c)
- 09/30/22
- Carnival sees net loss, breakeven to slightly negative adjusted EBITDA in Q4
- 09/30/22
- Carnival reports Q3 EPS (65c), consensus (13c)
- 09/29/22
- Notable companies reporting before tomorrow's open
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 11/10/22
- Yeti rises 29.9%
- 11/10/22
- Yeti rises 24.1%
- 11/10/22
- Yeti rises 21.6%
- 11/10/22
- Yeti jumps 5% to $32.00 after Q3 results beat estimates
- 11/09/22
- Veru announces update on FDA AdCom meeting on Sabizabulin as COVID treatment
- 11/09/22
- Veru trading halted, news pending
- 11/07/22
- Veru jumps 32% after FDA posts briefing documents for meeting of advisors
- 10/24/22
- Veru announces late-breaker oral presentation of sabizabulin treatment
- 10/02/22
- Fly Intel: Top five weekend stock stories
- 08/24/22
- Vacasa appoints Rob Greyber as next CEO
- 05/11/22
- Vacasa reports Q1 gross booking value up 101% to $494M
- $190.67 /
+13.03 (+7.34%) - 11/09/22
- Cathie Wood's ARK Investment bought 40K shares of Tesla today
- 11/09/22
- Musk sold almost $4B of Tesla stock after Twitter takeover
- 11/08/22
- Tesla recalls over 40,000 U.S. vehicles over power steering issue
- 11/06/22
- Fly Intel: Top five weekend stock stories
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 08/22/22
- TJX exec Canestrari sells 29,977 common shares
- 08/22/22
- TJX executive chairman Meyrowitz sells 70,720 common shares
- 08/22/22
- TJX exec Greenlees sells 8,822 common shares
- 11/10/22
- TG Therapeutics expects cash to fund operations into 2024
- 08/25/22
- TG Therapeutics announces resulst from the ULTIMATE I & II Phase 3 trials
- 06/27/22
- TG Therapeutics presents exploratory analyses from ublituximab in MS trial
- 06/03/22
- TG Therapeutics announces data presentations from ULTIMATE I, II Phase 3 trials
- $21.68 /
+2.515 (+13.12%) - 11/10/22
- Six Flags amends pact with H Partners allowing boost to beneficial ownership
- 08/23/22
- Six Flags rallies 7% to $24.08 after director reports $11.6M share purchase
- 08/23/22
- Six Flags director Rehan buys $11.6M worth of shares
- 08/11/22
- Six Flags falls -22.5%
- 08/22/22
- Chairman of Repay Holdings Kight buys over $1M in company shares
- 06/15/22
- Repay Holdings expands partnership with Hotel Investor Apps
- 05/18/22
- Corvia adds Repay as processing partner
- 05/16/22
- Repay Holdings approves $50M share repurchase program
- 11/10/22
- RingCentral rises 35.1%
- 11/10/22
- RingCentral rises 23.0%
- 11/10/22
- RingCentral rises 21.2%
- 11/09/22
- RingCentral jumps 9% to $31.08 after Q3 results beat ests, FY22 EPS view raised
- 11/10/22
- Ralph Lauren sees gross margin expansion in 2H
- 11/10/22
- Ralph Lauren sees FY23 gross margin up 30-50bps
- 11/10/22
- Ralph Lauren sees FY23 operating margins at low end of 14%-14.5% range
- 11/10/22
- Ralph Lauren expects choppiness to continue in NT, says consumer 'resilient'
- $32.95 /
+4.845 (+17.24%) - 11/09/22
- Rivian Automotive rallies 7% to $30.02 after keeping production outlook
- 11/09/22
- Rivian Automotive expects R2 platform to launch in 2026
- 11/09/22
- Rivian Automotive affirms 2022 production guidance 25,000 total units produced
- 11/09/22
- Rivian Automotive: Net R1 preorder backlog over 114,000 at November 7
- 11/10/22
- Redfin says annual home price growth slows to 3%
- 11/09/22
- Redfin to wind-down RedfinNow, lay off 13% of employees
- 11/09/22
- Redfin sinks 9% to $3.38 after shutting down house-flipping business
- 08/11/22
- RedfinNow announces its launch in Florida
- 11/09/22
- Cathie Wood's ARK Investment bought 333K shares of Roblox today
- 11/09/22
- Roblox falls 15% to $33.10 after Q3 results miss estimates
- 10/17/22
- Roblox rises 20.6%
- 10/17/22
- Roblox rises 15.1%
- $163.38 /
+11.83 (+7.81%) - 10/12/22
- Palo Alto Networks announces general availability of Cortex XSIAM
- 08/22/22
- Palo Alto Networks CEO: Most important thing in technology is product
- 08/22/22
- Palo Alto Networks CEO 'pleased' with Q4 results
- 08/22/22
- Palo Alto Networks jumps 6% to $538.80 after Q4 results, FY23 guidance top ests
- $10.33 /
+1.055 (+11.37%) - 11/01/22
- NIO delivers 10,059 vehicles in October, up 174.3%
- 10/27/22
- Nio, SKF expand strategic cooperation
- 10/24/22
- Nio falls -19.6%
- 10/24/22
- Nio falls -17.1%
- 10/25/22
- Marqeta announces partnership with Raiffeisen Centrobank
- 10/24/22
- Marqeta announces release of 'Marqeta for Banking' portfolio of products
- 10/06/22
- Uber partners with Marqeta, MasterCard and Branch on Uber Pro Card
- 09/15/22
- Marqeta announces $100M share repurchase program
- 10/27/22
- Society Pass' Thoughtful Media Group enters collaboration with Magnite
- 10/20/22
- Vizio leverages SpringServe Tiles to enhance content discovery
- 10/19/22
- Fox Corp. announces partnership with Magnite for OneFOX
- 09/21/22
- Magnite, Group Black collaborate to help Black-owned media scale their offering
- 11/10/22
- Ibex Ltd trading resumes
- 11/10/22
- Ibex Ltd trading halted, volatility trading pause
- 10/19/22
- Ibex to sponsor Execs In The Know event
- 10/17/22
- Ibex continues investment in employee development
- 09/22/22
- Edgio sets all-time traffic record, cites Amazon Thursday Night Football
- 08/22/22
- Edgio names Stephen Cumming CFO, Rich Diegman CLO
- 07/19/22
- Edgio names Darrin Reynolds Chief Information Security Officer
- 06/17/22
- Limelight completes acquisition of Yahoo's Edgecast, rebrands as 'Edgio'
- 06/13/22
- Viant names Dustin Kwan as chief product officer
- 10/26/22
- Digi International announces strategic agreement with UR Group
- 10/17/22
- DIG Restaurants collaborates with SmartSense by Digi
- 09/01/22
- Digi International selects MaxLinear PCIe bridges, serial transceivers
- 08/18/22
- SmartSense by Digi introduces Healthcare Advisory Board
- 09/12/22
- CytomX Therapeutics announces Phase 1 data for anti-CTLA-4 probody
- 07/13/22
- CytomX Therapeutics to restructure business, reduce workforce by 40%
- 07/06/22
- CytomX Therapeutics trading resumes
- 07/06/22
- CytomX Therapeutics to resume trading at 4:35 pm ET
- 11/10/22
- FTX US says trading may be halted 'in a few days'
- 11/09/22
- Cathie Wood's ARK Investment bought 238K shares of Coinbase today
- 11/09/22
- Crypto names down in pre-market as bitcoin falls below $17,200
- 11/08/22
- Cathie Wood's ARK Investment bought 421K shares of Coinbase today
- 10/17/22
- Cano Health falls -12.5%
- 10/10/22
- Cano Health falls -9.9%
- 10/07/22
- Cano Health rises 10.0%
- 10/07/22
- Cano Health off highs, up 5% to $9.29 after trade resumption
- $14.17 /
+2.405 (+20.44%) - 11/09/22
- Beyond Meat sees Q4 operating expenses mid-$60M range
- 11/07/22
- Beyond Meat expands chicken portfolio with Chicken Nuggets, Popcorn Chicken
- 10/24/22
- Beyond Meat debuts Beyond Steak
- 10/18/22
- Don Lee Farms settlement with Beyond Meat reached, no party admits wrongdoing
- 11/10/22
- FDA approves tremelimumab combo for metastatic non-small cell lung cancer
- 11/10/22
- Viatris wins court decision invalidating AstraZeneca's Symbicort patent
- 11/09/22
- AstraZeneca's PT027 recommended by FDA AdCom as asthma rescue treatment
- 11/07/22
- AstraZeneca reports Farxiga improved symptom burden in DELIVER Phase 3 trial
- 11/10/22
- Sony says 'Modern Warfare II' tops PS5 digital downloads in October
- 11/08/22
- Activision continues 'to work cooperatively with regulators' amid Microsoft deal
- 11/08/22
- U.S. video game spending fell 5% y/y in Q3, says NPD
- 11/08/22
- European Commission opens in-depth investigation into Activision takeover
- 10/05/22
- Digital Turbine announces investment in Aptoide app store
- 06/29/22
- Portland General Electric to replace Digital Turbine in S&P 400 at open on 6/29
- 06/29/22
- Digital Turbine to replace Tivity Health in S&P 600 at open on 6/29
- $96.55 /
+10.42 (+12.10%) - 11/10/22
- Amazon reveals new design for Prime Air's delivery drone due 2024
- 11/10/22
- Gap launches collection of 'family essentials' with Amazon Fashion
- 11/09/22
- Amazon announces disruption of three counterfeiting operations in China
- 11/09/22
- Amazon Web Services launches infrastructure region in Switzerland
- $32.95 /
+4.845 (+17.24%) - 11/10/22 RBC Capital
- Rivian Automotive price target lowered to $50 from $61 at RBC Capital
- 11/10/22 Deutsche Bank
- Rivian Automotive price target lowered to $43 from $44 at Deutsche Bank
- 11/10/22 Wedbush
- Rivian Automotive price target lowered to $37 from $45 at Wedbush
- 11/10/22 Canaccord
- Rivian Automotive price target lowered to $55 from $61 at Canaccord
- 11/09/22 DA Davidson
- Marqeta initiated with a Neutral at DA Davidson
- 10/20/22 Wedbush
- Marqeta to present at next week's Money2020 event, says Wedbush
- 10/10/22 Keefe Bruyette
- Marqeta price target lowered to $8 from $10 at Keefe Bruyette
- 09/28/22 Wedbush
- Endava price target lowered to $90 from $120 at Wedbush
- $21.68 /
+2.515 (+13.12%) - 11/11/22 William Blair
- Six Flags downgraded to Market Perform from Outperform at William Blair
- 11/08/22 Jefferies
- Six Flags downgraded to Hold at Jefferies ahead of 'transition' Q3
- 11/08/22 Jefferies
- Six Flags downgraded to Hold from Buy at Jefferies
- 11/02/22 Deutsche Bank
- Six Flags price target lowered to $32 from $38 at Deutsche Bank
- 11/10/22 Craig-Hallum
- RingCentral price target lowered to $60 from $110 at Craig-Hallum
- 11/10/22 Deutsche Bank
- RingCentral price target lowered to $50 from $70 at Deutsche Bank
- 11/10/22 Wells Fargo
- RingCentral price target lowered to $80 from $100 at Wells Fargo
- 11/10/22 Mizuho
- RingCentral price target lowered to $50 from $80 at Mizuho
- $10.33 /
+1.055 (+11.37%) - 11/11/22 BofA
- Nio price target lowered to $15 from $16 at BofA
- 11/11/22 Mizuho
- Nio price target lowered to $34 from $40 at Mizuho
- 11/10/22 Bernstein
- Nio price target lowered to $15 from $25 at Bernstein
- 11/08/22 Deutsche Bank
- Nio price target lowered to $20 from $39 at Deutsche Bank
- 11/10/22 Raymond James
- Activision Blizzard upgraded to Outperform from Market Perform at Raymond James
- 11/09/22 Wedbush
- Roblox price target lowered to $33 from $36 at Wedbush
- 10/13/22 Oppenheimer
- Oppenheimer sees more difficulty for Microsoft/Activision to win CMA approval
- 09/15/22 Atlantic Equities
- Electronic Arts downgraded to Neutral on valuation at Atlantic Equities
- 11/11/22 MKM Partners
- Roblox price target lowered to $35 from $40 at MKM Partners
- 11/10/22 Morgan Stanley
- Roblox assumed with an Equal Weight at Morgan Stanley
- 11/10/22 DA Davidson
- Roblox price target lowered to $50 from $55 at DA Davidson
- 11/10/22 JPMorgan
- JPMorgan downgrades Roblox on more modest sales growth outlook
- 11/11/22 Citi
- TJX price target raised to $86 from $78 at Citi
- 11/10/22 Gordon Haskett
- TJX upgraded to Buy at Gordon Haskett ahead of expected off-price improvement
- 11/10/22 Gordon Haskett
- TJX upgraded to Buy from Hold at Gordon Haskett
- 10/25/22 Morgan Stanley
- TJX price target raised to $80 from $77 at Morgan Stanley
- $163.38 /
+11.83 (+7.81%) - 11/10/22 Loop Capital
- Palo Alto Networks upgraded to Buy at Loop Capital on accelerating enterprise
- 11/10/22 Loop Capital
- Palo Alto Networks upgraded to Buy from Hold at Loop Capital
- 11/02/22 Macquarie
- Palo Alto Networks initiated with a Neutral at Macquarie
- 10/21/22 Needham
- Rapid7 downgraded to Hold at Needham on rising competitive risks
- 11/10/22 JPMorgan
- JPMorgan double downgrades 'show-me-story' CytomX Therapeutics
- 11/10/22 JPMorgan
- CytomX Therapeutics downgraded to Underweight from Overweight at JPMorgan
- 07/11/22 Cowen
- CytomX Therapeutics downgraded to Market Perform from Outperform at Cowen
- 07/11/22 H.C. Wainwright
- CytomX Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
- $96.55 /
+10.42 (+12.10%) - 11/07/22 Morgan Stanley
- Amazon outlook 'a warning shot for discretionary retailers,' says Morgan Stanley
- 11/02/22 Tigress Financial
- Amazon.com price target lowered to $192 from $232 at Tigress Financial
- 10/28/22 DA Davidson
- Amazon.com price target lowered to $114 from $151 at DA Davidson
- 10/28/22 Morgan Stanley
- Amazon price target lowered to $140 from $175 at Morgan Stanley
- 11/10/22 Citi
- Coinbase price target lowered to $80 from $105 at Citi
- 11/09/22 Daiwa
- Coinbase downgraded to Neutral from Buy at Daiwa
- 11/09/22 Barclays
- Potential acquisition of Robinhood by FTX likely off table, says Barclays
- 11/08/22 BTIG
- Binance-FTX deal may intensify Coinbase challenges, says BTIG
- 11/04/22 Citi
- Citi opens 'positive catalyst watch' AstraZeneca on NJ litigation outcomes
- 10/19/22 Berenberg
- AstraZeneca price target lowered to 118 GBp from 120 GBp at Berenberg
- 10/11/22 Guggenheim
- AstraZeneca price target lowered to 11,800 GBp from 12,000 GBp at Guggenheim
- 09/15/22 Credit Suisse
- AstraZeneca downgraded to Neutral from Outperform at Credit Suisse
- $190.67 /
+13.03 (+7.34%) - 11/10/22 Wedbush
- Tesla removed from 'Best Ideas' list at Wedbush
- 11/02/22 Bernstein
- Bernstein analysis shows Tesla total software run rate revenues of $290M/quarter
- 10/25/22 Canaccord
- Tesla price-cuts in China not unexpected, says Canaccord
- 10/25/22 Bernstein
- Tesla's apparent China demand woes appear driven by share losses, says Bernstein
- 09/26/22 Truist
- Ibex price target lowered to $22 from $26 at Truist
- 09/26/22 Citi
- Ibex price target lowered to $18 from $20 at Citi
- 09/23/22 Piper Sandler
- Ibex price target lowered to $20 from $21 at Piper Sandler
- 07/19/22 Citi
- Ibex assumed with Neutral from Buy at Citi
- 11/06/22 Barclays
- Repay Holdings price target lowered to $8 from $13 at Barclays
- 10/18/22 BTIG
- Repay Holdings price target lowered to $12 from $18 at BTIG
- 10/10/22 Keefe Bruyette
- Repay Holdings price target lowered to $8 from $13 at Keefe Bruyette
- 08/24/22 Canaccord
- Repay Holdings price target lowered to $20 from $25 at Canaccord
- 11/10/22 RBC Capital
- Redfin price target lowered to $5 from $10 at RBC Capital
- 11/10/22 Truist
- Redfin price target lowered to $10 from $16 at Truist
- 11/10/22 Compass Point
- Redfin downgraded to Sell from Neutral at Compass Point
- 11/10/22 Wedbush
- Redfin price target lowered to $4 from $9 at Wedbush
- 08/10/22 Susquehanna
- Magnite price target lowered to $13 from $24 at Susquehanna
- 08/02/22 Truist
- Magnite price target lowered to $13 from $15 at Truist
- 07/27/22 RBC Capital
- Google cookie phase-out delay adds another year of uncertainty, says RBC Capital
- 07/14/22 Stephens
- Stephens says Netflix choice may leave 'no economics' for Trade Desk, Magnite
- 11/10/22 Craig-Hallum
- Digital Turbine price target lowered to $30 from $60 at Craig-Hallum
- 10/31/22 Roth MKM
- Digital Turbine price target lowered to $20 from $32 at Roth Capital
- 10/17/22 BofA
- BofA starts Digital Turbine at Buy on niche focus and dominant market share
- 10/17/22 BofA
- Digital Turbine initiated with a Buy at BofA
- 06/13/22 B. Riley
- TG Therapeutics price target lowered to $17 from $23 at B. Riley
- 05/20/22 BofA
- BofA starts TG Therapeutics at Underperform, sees difficult commercial setup
- 05/20/22 BofA
- TG Therapeutics initiated with an Underperform at BofA
- 04/19/22 B. Riley
- TG Therapeutics application withdrawal 'clearing event,' says B. Riley
- 11/10/22 Northland
- Edgio downgraded to Market Perform from Outperform at Northland
- 11/10/22 Cowen
- Edgio downgraded to Market Perform from Outperform at Cowen
- 09/22/22 Northland
- Amazon TNF kickoff scores 'a win' for Edgio, says Northland
- 06/21/22 Cowen
- Edgio price target lowered to $5.00 from $5.50 at Cowen
- 11/10/22 JPMorgan
- Vacasa downgraded to Neutral on concerns into 2023 at JPMorgan
- 11/10/22 JPMorgan
- Vacasa downgraded to Neutral from Overweight at JPMorgan
- 10/31/22 Needham
- Vacasa price target lowered to $7 from $10 at Needham
- 10/03/22 Deutsche Bank
- Vacasa initiated with a Hold at Deutsche Bank
- 11/10/22 Cowen
- Cano Health downgraded at Cowen with liquidity 'now a plausible 2023 concern'
- 11/10/22 Cowen
- Cano Health downgraded to Market Perform from Outperform at Cowen
- 11/10/22 Raymond James
- Cano Health downgraded to Market Perform from Outperform at Raymond James
- 11/10/22 Raymond James
- Cano Health downgraded to Market Perform from Outperform at Raymond James
- 11/10/22 H.C. Wainwright
- Veru price target lowered to $21 from $24 at H.C. Wainwright
- 09/20/22 Oppenheimer
- Oppenheimer optimism for Veru's sabizabulin EUA remains 'unchanged'
- 09/08/22 Oppenheimer
- Oppenheimer remains bullish on Veru, optimism for EUA unchanged
- 08/11/22 Cantor Fitzgerald
- Veru price target raised to $30 from $24 at Cantor Fitzgerald
- 11/11/22 Baird
- Yeti price target lowered to $60 from $65 at Baird
- 11/11/22 Citi
- Yeti price target raised to $47 from $43 at Citi
- 11/11/22 Piper Sandler
- Yeti price target raised to $57 from $48 at Piper Sandler
- 11/07/22 Credit Suisse
- Yeti price target lowered to $60 from $70 at Credit Suisse
- $14.17 /
+2.405 (+20.44%) - 11/10/22 Bernstein
- Beyond Meat price target lowered to $10 from $22 at Bernstein
- 11/10/22 Mizuho
- Beyond Meat price target lowered to $11 from $27 at Mizuho
- 10/17/22 Canaccord
- Beyond Meat price target lowered to $14 from $15 at Canaccord
- 10/17/22 Barclays
- Beyond Meat price target lowered to $13 from $30 at Barclays
- 11/10/22 BofA
- BofA downgrades Viant, sees things getting worse before better
- 11/10/22 Canaccord
- Canaccord downgrades Viant to Hold on tough ad environment
- 11/10/22 Canaccord
- Viant downgraded to Hold from Buy at Canaccord
- 11/10/22 BofA
- Viant downgraded to Neutral from Buy at BofA
- 11/11/22 Cowen
- Ralph Lauren price target raised to $132 from $128 at Cowen
- 11/07/22 JPMorgan
- Ralph Lauren price target lowered to $131 from $133 at JPMorgan
- 11/04/22 Citi
- Ralph Lauren price target lowered to $92 from $96 at Citi
- 09/29/22 Citi
- Citi cuts VF target, says reduced outlook still 'somewhat aggressive'
- 11/11/22 Cantor Fitzgerald
- Digi International price target raised to $48 from $41 at Cantor Fitzgerald
- 11/11/22 Canaccord
- Digi International price target raised to $46 from $41 at Canaccord
- 11/10/22 Piper Sandler
- Digi International price target raised to $50 from $45 at Piper Sandler
- 09/08/22 Cantor Fitzgerald
- Digi International initiated with an Overweight at Cantor Fitzgerald
- 11/10/22
- Yeti sees FY22 adjusted EPS $2.36, consensus $2.37
- 11/10/22
- Yeti reports Q3 adjusted EPS 63c, consensus 58c
- 11/09/22
- Notable companies reporting before tomorrow's open
- 08/11/22
- Veru reports Q3 EPS (28c), consensus (18c)
- 05/12/22
- Veru reports Q2 EPS (18c), consensus (15c)
- 11/09/22
- Vacasa reports Q3 EPS 4c, consensus 7c
- 08/10/22
- Vacasa raises FY22 revenue view to $1.17B-$1.19B, consensus $1.15B
- 08/10/22
- Vacasa sees Q2 revenue $385M-$395M, consensus $388.5M
- 08/10/22
- Vacasa reports Q2 EPS 2c, consensus (19c)
- $190.67 /
+13.03 (+7.34%) - 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- 10/19/22
- Notable companies reporting after market close
- 07/20/22
- Tesla reports Q2 EPS $2.27, consensus $1.85
- 07/20/22
- Notable companies reporting after market close
- 08/17/22
- TJX sees Q3 revenue $12.1B-$12.3B, consensus $12.92B
- 08/17/22
- TJX cuts FY23 revenue view to $49.6B-$49.9B from $51.3B-$51.8B
- 08/17/22
- TJX sees Q4 adjusted EPS 92c-96c
- 08/17/22
- TJX backs FY23 adjusted EPS view $3.13-$3.20
- 11/10/22
- TG Therapeutics reports Q3 EPS (26c), consensus (39c)
- 08/08/22
- TG Therapeutics reports Q2 EPS (30c), consensus (51c)
- $21.68 /
+2.515 (+13.12%) - 11/10/22
- Six Flags reports Q3 EPS $1.39, consensus $1.60
- 08/11/22
- Six Flags reports Q2 EPS 53c, consensus $1.02
- 08/10/22
- Notable companies reporting before tomorrow's open
- 11/09/22
- Repay Holdings reports Q3 adjusted EPS 24c, consensus 20c
- 11/09/22
- Repay Holdings backs FY22 revenue view $268M-$286M, consensus $276.19M
- 08/09/22
- Repay Holdings cuts FY22 revenue view to $268M-$286M from $296M-$306M
- 08/09/22
- Repay Holdings reports Q2 EPS 0c vs. (15c) last year
- 11/09/22
- RingCentral raises FY 22 EPS view to $1.97-$1.98 from $1.91-$1.95
- 11/09/22
- RingCentral sees Q4 EPS 59c-60c, consensus 59c
- 11/09/22
- RingCentral reports Q3 EPS 55c, consensus 50c
- 11/10/22
- Ralph Lauren sees FY23 revenue up about 8%, consensus $6.32B
- 11/10/22
- Ralph Lauren backs FY23 revenue view up high-single digits, consensus $6.32B
- 11/10/22
- Ralph Lauren sees Q3 revenue up low- to mid-single digits, consensus $1.8B
- 11/10/22
- Ralph Lauren reports Q2 adjusted EPS $2.23, consensus $2.08
- $32.95 /
+4.845 (+17.24%) - 11/09/22
- Rivian Automotive reports Q3 adjusted EPS ($1.57), consensus ($1.82)
- 11/09/22
- Notable companies reporting after market close
- 10/27/22
- Amazon reports Q3 EPS 28c with Rivian gain, consensus 21c
- 08/11/22
- Rivian Automotive reports Q2 EPS ($1.89), consensus ($1.67)
- 11/09/22
- Redfin sees Q4 revenue $430M-$459M, consensus $560.16M
- 11/09/22
- Redfin reports Q3 EPS (83c), consensus (80c)
- 08/04/22
- Redfin sees Q3 revenue $590M-$627M, consensus $626.7M
- 08/04/22
- Redfin reports Q2 EPS (73c), consensus (60c)
- 11/09/22
- Roblox reports Q3 EPS (50c), consensus (33c)
- 11/08/22
- Notable companies reporting before tomorrow's open
- 08/09/22
- Roblox reports Q2 EPS (30c), consensus (23c)
- $163.38 /
+11.83 (+7.81%) - 08/22/22
- Palo Alto Networks sees FY23 adjusted EPS $9.40-$9.50, consensus $9.26
- 08/22/22
- Palo Alto Networks sees Q1 adjusted EPS $2.03-$2.06, consensus $2.04
- 08/22/22
- Palo Alto Networks reports Q4 adjusted EPS $2.39, consensus $2.28
- 08/22/22
- Notable companies reporting after market close
- $10.33 /
+1.055 (+11.37%) - 11/10/22
- Nio reports Q3 adjusted EPS (30c), consensus (16c)
- 09/07/22
- Nio sees Q3 revenue $1.92B-$2.03B, consensus $2.32B
- 09/07/22
- Nio reports Q2 adjusted EPS (20c), consensus (17c)
- 06/09/22
- Nio sees Q2 revenue $1.473B-$1.591B, consensus $1.86B
- 11/09/22
- Marqeta sees Q4 revenue up 29%-31%, consensus $191M
- 11/09/22
- Marqeta reports Q3 EPS (10c), consensus (9c)
- 08/10/22
- Marqeta sees Q3 revenue growth 36%-38%, consensus $180.05M
- 11/09/22
- Magnite reports Q3 EPS 18c, consensus 14c
- 08/09/22
- Magnite sees Q3 revenue $122M-$126M, consensus $130.83M
- 08/09/22
- Magnite reports Q2 EPS 14c vs. 11c last year
- 09/22/22
- Ibex sees FY23 revenue $545M-$555M, consensus $546.81M
- 09/22/22
- Ibex sees Q1 revenue $124-$127M, consensus $124.66M
- 09/22/22
- Ibex reports Q4 adjusted EPS 42c, consensus 45c
- 05/18/22
- Ibex backs FY22 outlook
- 11/09/22
- Edgio sees Q4 revenue $109M-$114M, consensus $130.66M
- 11/09/22
- Edgio reports Q3 EPS (19c), consensus (5c)
- 08/08/22
- Edgio sees FY22 revenue $380M-$390M, $401.86M
- 08/08/22
- Edgio reports Q2 EPS (11c), consensus (3c)
- 11/09/22
- Viant sees Q4 revenue $52M-$57M, consensus $81.65M
- 11/09/22
- Viant reports Q3 adjusted EPS (6c), consensus (18c)
- 08/09/22
- Viant withdraws FY22 revenue, adjusted EBITDA guidance
- 08/09/22
- Viant sees Q3 revenue $47.5M-$50M, consensus $63.27M
- 11/10/22
- Digi International sees Q1revenue $101M-$105M, consensus $100.51M
- 11/10/22
- Digi International reports Q4 EPS 45c, consensus 41c
- 08/04/22
- Digi International sees Q3 EPS 45c, consensus 37c
- 08/04/22
- Digi International reports Q3 EPS 45c, consensus 37c
- 11/08/22
- CytomX Therapeutics reports Q3 EPS (35), consensus (31c)
- 08/04/22
- CytomX Therapeutics reports Q2 EPS (37c), consensus (36c)
- 11/03/22
- Coinbase reports Q3 EPS ($2.43), consensus ($2.40)
- 11/03/22
- Notable companies reporting after market close
- 08/09/22
- Coinbase reports Q2 EPS ($4.98), consensus ($2.65)
- 08/09/22
- Coinbase reports Q2 EPS ($4.98), consensus ($2.65)
- 11/09/22
- Cano Health lowers FY22 revenue view to $2.70B-$2.75B from $2.85B-$2.90B
- 11/09/22
- Cano Health reports Q3 EPS (23c), consensus (5c)
- 08/09/22
- Cano Health raises FY22 revenue view to $2.85B-$2.9B from $2.8B-$2.9B
- 08/09/22
- Cano Health reports Q2 EPS (3c), consensus (5c)
- $14.17 /
+2.405 (+20.44%) - 11/09/22
- Beyond Meat cuts FY22 revenue view to $400M-$425M from $470M-$520M
- 11/09/22
- Beyond Meat reports Q3 EPS ($1.60), consensus ($1.14)
- 10/14/22
- Beyond Meat sees Q3 revenue $82M, consensus $117.11M
- 11/10/22
- AstraZeneca raises FY22 core EPS view to high 20s to low 30s percentage
- 11/10/22
- AstraZeneca reports Q3 core EPS $1.67, YTD core EPS $5.28
- 07/29/22
- AstraZeneca backs FY22 core EPS view up by mid to high twenties percentage
- 07/29/22
- AstraZeneca reports Q2 core EPS $1.72, up 89% year-over-year
- 11/07/22
- Activision Blizzard reports Q3 adjusted EPS 68c, consensus 50c
- 11/07/22
- Notable companies reporting after market close
- 08/01/22
- Activision Blizzard reports Q2 adjusted EPS 48c, consensus 48c
- 08/01/22
- Notable companies reporting after market close
- 11/09/22
- Digital Turbine sees Q3 adjusted EPS 36c-39c, consensus 38c
- 11/09/22
- Digital Turbine reports Q2 non-GAAP EPS 34c, consensus 33c
- 08/08/22
- Digital Turbine sees Q2 adjusted EPS 32-34c, consensus 37c
- 08/08/22
- Digital Turbine reports Q1 adjusted EPS 38c, consensus 35c
- $96.55 /
+10.42 (+12.10%) - 10/27/22
- Amazon sees Q4 revenue $140B-$148B, consensus $155.15B
- 10/27/22
- Notable companies reporting after market close
- 07/28/22
- Amazon reports Q2 AWS net sales $19.73B vs. $14.81B a year ago
- 07/08/22
- Culper Research says short Veru, sees ' little to no hope of' sabizabulin EUA
- 10/01/22
- SPAC bubble has burst, Blue Owl Luminar still have potential, Barron's says
- $190.67 /
+13.03 (+7.34%) - 11/10/22
- Tesla cancels solar projects in mass across U.S., Electrek reports
- 11/09/22
- Zoom announces official integration into Tesla vehicles, Electrek reports
- 11/05/22
- Twitter is Musk's biggest test, Tesla's biggest challenge, Barron's says
- 11/02/22
- Tesla shut flagship China showroom in October, Bloomberg reports
- 10/15/22
- Shortages have turned to gluts, off-price retailers could benefit, Barron's says
- 05/21/22
- TJX among off-price retailers looking like bargains, Barron's says
- $21.68 /
+2.515 (+13.12%) - 08/15/22
- Three people injured in shooting outside Six Flags Great America, WSJ reports
- 08/05/22
- RingCentral to lay off 50 employees at Belmont HQ, SFBT reports
- $32.95 /
+4.845 (+17.24%) - 11/07/22
- Amazon has 'hundreds' of Rivian vans making deliveries, The Verge reports
- 10/19/22
- Rivian has fixed 'majority' of recalled vehicles, TechCrunch reports
- 08/19/22
- Rivian drops cheapest version of electric pickup truck, Bloomberg reports
- 08/02/22
- Rivian says most vehicles ineligible under Senate climate deal, WSJ reports
- 10/06/22
- Roblox sued by watchdog group over girl's exploitation, Bloomberg reports
- 09/09/22
- Roblox planning to debut ads in 2023, CNBC reports
- 08/19/22
- Roblox hires seasoned Meta executive, WSJ reports
- $163.38 /
+11.83 (+7.81%) - 10/21/22
- Cybereason taps JPMorgan to help find buyer, The Information says
- 09/19/22
- Palo Alto Networks near deal to buy Apiiro for about $600M, Calcalist says
- $10.33 /
+1.055 (+11.37%) - 06/28/22
- Nio plays 'accounting games' to inflate revenue, short-seller Grizzly claims
- 06/25/22
- Lucid stock looks more vulnerable than Tesla, other peers, Barron's says
- 06/10/22
- Nio to start making self-developed battery packs in 2024, Reuters says
- 06/06/22
- Nio looking to hire professionals to build U.S. plant, DigiTimes reports
- 06/21/22
- Magnite, Google emerging as possible ad partners for Netflix, AdAge says
- 11/10/22
- CVC Capital discussing potential bid for Ibex, Bloomberg says
- 11/10/22
- Ibex jumps after Bloomberg says CVC Capital considering bid
- 11/10/22
- CVC Capital discussing potential bid for Ibex, Bloomberg says
- 11/10/22
- Coinbase cutting more jobs, The Information reports
- 11/09/22
- Binance walks away from FTX deal due to issues 'beyond our control,' WSJ reports
- 11/09/22
- Binance walking away from FTX deal, WSJ reports
- 11/09/22
- SEC expands probe into FTX, WSJ reports
- 10/17/22
- CVS decided against pursuing deal with Cano Health, Dealreporter says
- 10/07/22
- Cano jumps after Bloomberg says CVS in exclusive buyout talks
- 10/07/22
- CVS said in exclusive to talks to buy Cano Health, Bloomberg reports
- 09/22/22
- CVS Health said to weigh possible bid for Cano Health, Bloomberg says
- $14.17 /
+2.405 (+20.44%) - 10/13/22
- Beyond Meat to cut more jobs in addition to August layoffs, Bloomberg says
- 09/20/22
- Beyond Meat COO arrested over the weekend, CNBC reports
- 08/04/22
- Beyond Meat eliminates about 40 positions amid cost cutting, Bloomberg reports
- 07/29/22
- McDonald's tells CNBC it ended U.S. McPlant test
- 11/10/22
- AstraZeneca drops plans to submit COVID-19 vaccine to U.S. FDA, WSJ reports
- 10/20/22
- Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports
- 08/23/22
- AstraZeneca tells Reuters it may not stay in vaccine business long-term
- 08/16/22
- AstraZeneca sues former dealmaker for sharing data with GSK, Bloomberg reports
- 11/09/22
- New 'Call of Duty' launch sales in U.K. up 92% from last release, GI.biz says
- 11/06/22
- Activision insiders fret Microsoft merger could fall apart, NY Post reports
- 11/02/22
- Activision Blizzard files to appeal NLRB Albany decision, Polygon says
- 11/01/22
- E.U. set to launch investigation into Microsoft-Activision, POLITICO reports
- $96.55 /
+10.42 (+12.10%) - 11/10/22
- Amazon debuts new robot arm Sparrow, TechCrunch reports
- 11/10/22
- Amazon launches cost cutting review, WSJ reports
- 11/10/22
- Amazon is first public company to lose $1T in market value, Bloomberg reports
- 08/11/22
- What You Missed On Wall Street On Thursday
- 08/11/22
- What You Missed On Wall Street This Morning
- $190.67 /
+13.03 (+7.34%) - 11/02/22
- What You Missed On Wall Street On Wednesday
- 08/17/22
- What You Missed On Wall Street On Wednesday
- $21.68 /
+2.515 (+13.12%) - 11/10/22
- Fly Intel: Pre-market Movers
- 11/08/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 07/22/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/01/22
- What You Missed This Week in Video Games
- 08/09/22
- What You Missed On Wall Street On Tuesday
- $32.95 /
+4.845 (+17.24%) - 11/10/22
- What You Missed On Wall Street On Thursday
- 11/10/22
- What You Missed On Wall Street This Morning
- 11/09/22
- Fly Intel: After-Hours Movers
- 11/07/22
- What You Missed This Week in EVs and Clean Energy
- 11/07/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/04/22
- Fly Intel: After-Hours Movers
- 11/09/22
- What You Missed On Wall Street On Wednesday
- $163.38 /
+11.83 (+7.81%) - 11/02/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/09/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 07/27/22
- Ad tech stocks pop as Chrome said to push out tracking cookie deadline
- 07/19/22
- What Wall Street is saying about Netflix ahead of earnings
- 09/23/22
- What You Missed On Wall Street On Friday
- 09/23/22
- What You Missed On Wall Street This Morning
- 07/07/22
- Fly Intel: Pre-market Movers
- 11/09/22
- What You Missed On Wall Street This Morning
- 10/17/22
- What You Missed On Wall Street This Morning
- $14.17 /
+2.405 (+20.44%) - 10/14/22
- What You Missed On Wall Street On Friday
- 10/05/22
- Biotech Alert: Searches spiking for these stocks today
- 11/10/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/08/22
- What You Missed On Wall Street On Tuesday
- 10/17/22
- What You Missed On Wall Street On Monday
- $96.55 /
+10.42 (+12.10%) - 11/07/22
- What You Missed On Wall Street On Monday
- 11/07/22
- What You Missed On Wall Street This Morning
- 09/16/22
- YETI Holdings call volume above normal and directionally bullish
- 08/01/22
- YETI Holdings call buyer realizes 64% same-day gains
- 11/08/22
- Unusually active option classes on open November 8th
- 11/07/22
- Unusually active option classes on open November 7th
- 11/03/22
- Veru put volume heavy and directionally bearish
- 11/02/22
- Veru put volume heavy and directionally bearish
- $190.67 /
+13.03 (+7.34%) - 11/08/22
- Notable open interest changes for November 8th
- 06/28/22
- TJX call volume above normal and directionally bullish
- 05/20/22
- TJX put volume heavy and directionally bearish
- 05/18/22
- Early notable gainers among liquid option names on May 18th
- 05/18/22
- Unusually active option classes on open May 18th
- 06/09/22
- Unusually active option classes on open June 9th
- $21.68 /
+2.515 (+13.12%) - 08/23/22
- Six Flags call volume above normal and directionally bullish
- 11/09/22
- Ringcentral options imply 13.9% move in share price post-earnings
- 11/04/22
- Ringcentral call volume above normal and directionally bullish
- 10/11/22
- Ringcentral call volume above normal and directionally bullish
- 10/03/22
- RingCentral Inc put volume heavy and directionally bearish
- $32.95 /
+4.845 (+17.24%) - 11/09/22
- Rivian options imply 10.8% move in share price post-earnings
- 10/10/22
- Unusually active option classes on open October 10th
- 10/06/22
- Unusually active option classes on open October 6th
- 09/29/22
- Unusually active option classes on open September 29th
- 11/09/22
- Redfin options imply 16.5% move in share price post-earnings
- 10/03/22
- Redfin Corp call volume above normal and directionally bullish
- 09/06/22
- Redfin put volume heavy and directionally bearish
- 08/15/22
- Redfin put volume heavy and directionally bearish
- 10/18/22
- Notable open interest changes for October 18th
- 10/17/22
- Unusually active option classes on open October 17th
- 10/06/22
- Roblox Corp put volume heavy and directionally bearish
- 08/10/22
- Roblox put buyer realizes 18% same-day gains
- $163.38 /
+11.83 (+7.81%) - 09/28/22
- Largest borrow rate increases among liquid names
- 09/15/22
- Notable open interest changes for September 15th
- 08/22/22
- Palo Alto Networks options imply 7.6% move in share price post-earnings
- 05/19/22
- Palo Alto Networks options imply 9.5% move in share price post-earnings
- $10.33 /
+1.055 (+11.37%) - 10/31/22
- NIO call volume above normal and directionally bullish
- 10/20/22
- Unusually active option classes on open October 20th
- 10/20/22
- Notable open interest changes for October 20th
- 10/07/22
- NIO call volume above normal and directionally bullish
- 11/09/22
- Marqeta options imply 11.6% move in share price post-earnings
- 08/22/22
- Unusually active option classes on open August 22nd
- 08/10/22
- Marqeta options imply 10.3% move in share price post-earnings
- 05/11/22
- Marqeta options imply 14.9% move in share price post-earnings
- 11/09/22
- Unusually active option classes on open November 9th
- 11/08/22
- Coinbase put buyer realizes 72% same-day gains
- 11/07/22
- Coinbase put volume heavy and directionally bearish
- 11/09/22
- Cano Health options imply 13.0% move in share price post-earnings
- 10/12/22
- Cano Health put volume heavy and directionally bearish
- 10/10/22
- Cano Health put volume heavy and directionally bearish
- 10/05/22
- Cano Health put volume heavy and directionally bearish
- $14.17 /
+2.405 (+20.44%) - 11/09/22
- Beyond Meat options imply 14.7% move in share price post-earnings
- 10/31/22
- Beyond Meat put volume heavy and directionally bearish
- 10/28/22
- Largest borrow rate increases among liquid names
- 10/25/22
- Beyond Meat call volume above normal and directionally bullish
- 11/08/22
- AstraZeneca put volume heavy and directionally bearish
- 10/11/22
- AstraZeneca call volume above normal and directionally bullish
- 09/12/22
- AstraZeneca call volume above normal and directionally bullish
- 07/20/22
- AstraZeneca call volume above normal and directionally bullish
- 08/19/22
- Activision Blizzard call volume above normal and directionally bullish
- 08/09/22
- Activision Blizzard put volume heavy and directionally bearish
- 08/01/22
- Activision Blizzard options imply 2.6% move in share price post-earnings
- 11/09/22
- Digital Turbine options imply 15.1% move in share price post-earnings
- 11/02/22
- Digital Turbine call volume above normal and directionally bullish
- 10/27/22
- Largest borrow rate increases among liquid names
- 10/26/22
- Digital Turbine put volume heavy and directionally bearish
- $96.55 /
+10.42 (+12.10%) - 11/10/22
- Notable open interest changes for November 10th
- 11/09/22
- Notable open interest changes for November 9th
- 11/07/22
- Notable open interest changes for November 7th
- 11/04/22
- Notable open interest changes for November 4th
|
